Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 10th January 2022 Vol. No. 11; Issue No. 508

1. Khanna N, Ghosh Laskar S, Gupta T, Agarwal JP (2022). Compliance with radiotherapy treatment in an apex cancer center of India. JCO Global Oncology. e2100201.

2. Jain A, Nayak L, Kulkarni UP, Mehra N, Yanamandra U, Kayal S, Damodar S, John JM, Mehta P, Singh S, Munot P, Selvarajan S, Radhakrishnan V, Lad D, Kapoor R, Dubashi B, Bharath RS, Jain H, Jayachandran PK, Lakshmanan J, Mani T, Thorat J, Das S, Karunamurthy O, George B, Sengar M, Malhotra P (2022). Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India. Blood Cancer Journal. 12(1):2.

Site of the Week

ProtScale allows you to compute and represent the profile produced by any amino acid scale on a selected protein.

desktop Image
Interesting Reads

Hecht SS, Hatsukami DK. (2022) Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer.

Legends of Science
Manchanahalli Rangaswamy Satyanarayana Rao Manchanahalli Rangaswamy Satyanarayana Rao

M R Satyanarayana Rao, doctorate from the Indian Institute of Science, Bangalore in 1973 worked on the regulation of heme synthesis in liver. He initiated various genomics programs at IISc and worked on the role of Vitamin A in cellular differentiation. Credited as the first scientist to initiate Chromatin Biology Research in India, he is actively running Chromatin Biology Laboratory at the Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore. He was Member, Scientific Advisory Groups, ICMR, 2012-2017 and Chairman of Basic Medical Science, ICMR during 2014-2017. He has been awarded with Shanti Swaup Bhatnagar Award in 1988 and Padma Shri in 2010.

Umesh Varshney Umesh Varshney

Umesh Varshney received his PhD degree from the University of Calgary, Canada in 1985. His primary research area is protein synthesis and DNA repair in Escherichia coli and Mycobacterium tuberculosis. Dr Varshney's efforts were instrumental in bringing together a group of scientists in India interested in RNA research known as 'RNA Group'. Currently the Chairman of the division of Biological Sciences, at the IISc, he is the collaborator of the Genome Metabolism and Biostruct Laboratory, Budapest. Dr. Varshney has been awarded with Shanti Swarup Bhatnagar Award in 2001; G N Ramachandran Gold Medal for Excellence in Biological Science & Technology in 2014.

Upcoming Events
Geriatric Oncology: Cognition and Communication - Winter 2022

27-28 January, 2022

Virtual, Memorial Sloan Kettering Cancer Center, New York.

Certified Tobacco Treatment Training Program

24-28 January, 2022

Virtual, MD Anderson Cancer Center, Houston, TX.

2nd Onco-Bronchology International Conference

20-21 January, 2022

In-Person and Virtual at JW Marriott Hotel, Cairo, Egypt.

Do You Know?

In 2007, a large study showed that a new drug, Sorafenib( Nexavar), extends the lives of patients with advanced, inoperable hepatocellular carcinoma.

back Image
Cancer News
Secondary structures in DNA are associated with cancer

03 January 2022, MedicalXpress

A new cancer study reports that DNA manifested as knot-like folds and third rungs between DNA's two strands may drive cancer development, and an important regulatory enzyme could be associated with the formation of these unusual structures...

First time genome editing made possible on cells lining blood vessel walls

04 January 2022, ScienceDaily

Researchers have developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to endothelial cells, which are cells that line blood vessel walls. This is the first time that vascular endothelial cells could be reached for genome editing, since the usual way to deliver CRISPR/Cas9 -- through a virus -- does not work for this cell type...

5-gram increase in fiber intake may lower melanoma progression by 30%

05 January 2022, MedicalNewsToday

In a new observational study, Prof. Wargo and her colleagues found that people with melanoma who ate a high-fiber diet responded better to immune therapy.These individuals were significantly more likely to survive without their cancer worsening after around 13 months of treatment.ogression by 30%....

© 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)